{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T00:44:28Z","timestamp":1791852268806,"version":"4.3.4"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005795","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005795","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012553","name":"Chang Gung Memorial Hospital","doi-asserted-by":"publisher","award":["CMRPD1N0051"],"award-info":[{"award-number":["CMRPD1N0051"]}],"id":[{"id":"10.13039\/100012553","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020595","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["MOST-110-2320-B-182-011-MY3"],"award-info":[{"award-number":["MOST-110-2320-B-182-011-MY3"]}],"id":[{"id":"10.13039\/100020595","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Biomaterialia"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/j.actbio.2023.11.040","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T18:18:29Z","timestamp":1701800309000},"page":"331-344","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Neutrophil-targeted combinatorial nanosystems for suppressing bacteremia-associated hyperinflammation and MRSA infection to improve survival rates"],"prefix":"10.1016","volume":"174","author":[{"given":"Yen-Tzu","family":"Chang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng-Yu","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Jung","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5728-9875","authenticated-orcid":false,"given":"Erica","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4290-2144","authenticated-orcid":false,"given":"Abdullah","family":"Alshetaili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3030-0560","authenticated-orcid":false,"given":"Huang-Ping","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia-You","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.actbio.2023.11.040_bib0001","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1038\/s41579-023-00852-y","article-title":"Staphylococcus aureus host interactions and adaptation","volume":"21","author":"Howden","year":"2023","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0002","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/s41579-018-0147-4","article-title":"Methicillin-resistant Staphylococcus aureus: an overview of basic and clinical research","volume":"17","author":"Turner","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0003","first-page":"e31486","article-title":"An update on treatment options for methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: a systematic review","volume":"14","author":"Mahjabeen","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.actbio.2023.11.040_bib0004","doi-asserted-by":"crossref","first-page":"691","DOI":"10.3389\/fimmu.2018.00691","article-title":"Inflammatory mediator profiles differ in sepsis patients with and without bacteremia","volume":"9","author":"Mosevoll","year":"2018","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0005","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.cell.2020.07.040","article-title":"Mortality risk profiling of Staphylococcus aureus bacteremia by multi-omic serum analysis reveals early predictive and pathogenic signatures","volume":"182","author":"Wazniak","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.actbio.2023.11.040_bib0006","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271115","article-title":"Relationship between mortality and molecular epidemiology of methicillin-resistant Staphylococcus aureus bacteremia","volume":"17","author":"Shimizu","year":"2022","journal-title":"PLoS ONE"},{"key":"10.1016\/j.actbio.2023.11.040_bib0007","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2017.17687","article-title":"Enhancing recovery from sepsis: a review","volume":"319","author":"Prescott","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.actbio.2023.11.040_bib0008","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jconrel.2020.02.030","article-title":"Inflammation-targeting polymeric nanoparticles deliver sparfloxacin and tacrolimus for combating acute lung sepsis","volume":"321","author":"Yang","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2023.11.040_bib0009","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.3389\/fimmu.2020.01318","article-title":"Glucocorticoids in sepsis: to be or not to be","volume":"11","author":"Vandewalle","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s13054-017-1801-3","article-title":"Incidence, prevalence, and management of MRSA bacteremia across patient populations\u2012a review of recent developments in MRSA management and treatment","volume":"21","author":"Hassoun","year":"2017","journal-title":"Crit. Care"},{"key":"10.1016\/j.actbio.2023.11.040_bib0011","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100864","article-title":"Coagulopathy and sepsis: pathophysiology, clinical manifestations and treatment","volume":"50","author":"Giustozzi","year":"2021","journal-title":"Blood Rev"},{"key":"10.1016\/j.actbio.2023.11.040_bib0012","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1001\/jama.2020.0103","article-title":"Australian Society for Infectious Diseases Clinical Research Network, Effect of vancomycin with vs without an antistaphylococcal \u03b2-lactam on mortality, bacteremia, relapse, or treatment failure in patients with MRSA bacteremia: a randomized clinical trial","volume":"323","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/j.actbio.2023.11.040_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202001378","article-title":"Nanotools for sepsis diagnosis and treatment","volume":"10","author":"Papafilippou","year":"2021","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.actbio.2023.11.040_bib0014","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/s41565-022-01137-w","article-title":"NAD(H)-loaded nanoparticles for efficient sepsis therapy via modulating immune and vascular homeostasis","volume":"17","author":"Ye","year":"2022","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0015","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4161\/viru.26514","article-title":"The complex pathogenesis of bacteremia: from antimicrobial clearance mechanisms to the genetic background of the host","volume":"5","author":"Christaki","year":"2014","journal-title":"Virulence"},{"key":"10.1016\/j.actbio.2023.11.040_bib0016","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/imr.13163","article-title":"Microbes and the fate of neutrophils","volume":"314","author":"Kobayashi","year":"2023","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.actbio.2023.11.040_bib0017","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s40824-021-00246-2","article-title":"Immune cell targeting nanoparticles: a review","volume":"25","author":"Lee","year":"2021","journal-title":"Biomater. Res."},{"key":"10.1016\/j.actbio.2023.11.040_bib0018","first-page":"1016","article-title":"The molecular biology of phosphodiesterase 4 enzymes as pharmacological targets: an interplay of isoforms, conformational states, and inhibitors","volume":"73","author":"Paes","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.actbio.2023.11.040_bib0019","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.3389\/fphar.2018.01048","article-title":"Phosphodiesterase-4 inhibitors for the treatment of inflammatory diseases","volume":"9","author":"Li","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106906","article-title":"Current insights on clinical efficacy of roflumilast for treatment of COPD, asthma and ACOS","volume":"88","author":"Bodkhe","year":"2020","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0021","doi-asserted-by":"crossref","first-page":"25523","DOI":"10.1073\/pnas.2008577117","article-title":"Fusidic acid resistance through changes in the dynamics of the drug target","volume":"117","author":"Tomlinson","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.actbio.2023.11.040_bib0022","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2021.759220","article-title":"Bioactivities and structure-activity relationships of fusidic acid derivatives: a review","volume":"12","author":"Long","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0023","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1016\/S0142-9612(01)00291-5","article-title":"Dexamethasone\/PLGA microsphere for continuous delivery of an anti-inflammatory drug for implantable medical devices","volume":"23","author":"Hickey","year":"2002","journal-title":"Biomaterials"},{"key":"10.1016\/j.actbio.2023.11.040_bib0024","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12951-018-0364-z","article-title":"Use of cilomilast-loaded phosphatiosomes to suppress neutrophilic inflammation for attenuating acute lung injury: the effect of nanovesicular surface charge","volume":"16","author":"Liu","year":"2018","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0025","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ijpharm.2006.11.016","article-title":"The effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsion","volume":"335","author":"Hung","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2023.11.040_bib0026","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1039\/D0TB00158A","article-title":"Hybrid silver-gold nanoparticles suppress drug resistant polymicrobial biofilm formation and intracellular infection","volume":"8","author":"Bhatia","year":"2020","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.actbio.2023.11.040_bib0027","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12951-021-00789-5","article-title":"Multifunctional lipid-based nanocarriers with antibacterial and anti-inflammatory activities for treating MRSA bacteremia in mice","volume":"19","author":"Liao","year":"2021","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0028","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/cid\/ciab452","article-title":"Current paradigms of combination therapy in methicillin-resistant Staphylococcus aureus (MRSA) bacteremia: does it work, which combination, and for which patients?","volume":"73","author":"Rose","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.actbio.2023.11.040_bib0029","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1039\/C6SC02403C","article-title":"Antibody fragments as nanoparticle targeting ligands: a step in the right direction","volume":"8","author":"Richards","year":"2017","journal-title":"Chem. Sci."},{"key":"10.1016\/j.actbio.2023.11.040_bib0030","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12879-021-06010-0","article-title":"Cytokine measurements add value to clinical variable in predicting outcomes for Staphylococcus aureus bacteremia","volume":"21","author":"Tan","year":"2021","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.actbio.2023.11.040_bib0031","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.2100229","article-title":"Macrophagic extracellular vesicle CXCL2 recruits and activates the neutrophil CXCR2\/PKC\/NOX4 axis in sepsis","volume":"207","author":"Wang","year":"2021","journal-title":"J. Immunol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0032","first-page":"27","article-title":"Staphylococcus aureus bacteremia in patients not meeting sepsis criteria: clinical features, host immune response and outcomes","volume":"2","author":"Salas","year":"2017","journal-title":"J. Clin. Med. Ther."},{"key":"10.1016\/j.actbio.2023.11.040_bib0033","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s13054-018-2025-x","article-title":"Distinct T-helper cell responses to Staphylococcus aureus bacteremia reflect immunologic comorbidities and correlate with mortality","volume":"22","author":"Greenberg","year":"2018","journal-title":"Crit. Care"},{"key":"10.1016\/j.actbio.2023.11.040_bib0034","article-title":"Increased cytokine levels assist in the disgnosis of respiratory bacterial infections or concurrent bacteremia in patients with non-Hodgkin's lymphoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0035","doi-asserted-by":"crossref","first-page":"3813","DOI":"10.1007\/s00018-013-1286-4","article-title":"Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: similarities and differences","volume":"70","author":"Pillay","year":"2013","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.actbio.2023.11.040_bib0036","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3389\/fimmu.2019.00819","article-title":"Emerging role of lymphocyte antigen-6 family of genes in cancer and immune cells","volume":"10","author":"Upadhyay","year":"2019","journal-title":"Front. Immunol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0037","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/JLB.3A0520-081RR","article-title":"The neutrophil subset defined by CD177 expression is preferentially recruited to gingival crevicular fluid in periodontitis","volume":"109","author":"Rudin","year":"2021","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0038","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1039\/D2BM01521H","article-title":"Targeting anti-inflammatory immunonanocarriers to human and murine neutrophils via Ly6 antigen for psoriasiform dermatitis alleviation","volume":"11","author":"Lin","year":"2023","journal-title":"Biomater. Sci."},{"key":"10.1016\/j.actbio.2023.11.040_bib0039","first-page":"e22112","article-title":"Sepsis management, controversies, and advancement in nanotechnology: a systematic review","volume":"14","author":"Choudhary","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.actbio.2023.11.040_bib0040","doi-asserted-by":"crossref","first-page":"25523","DOI":"10.1073\/pnas.2008577117","article-title":"Fusidic acid resistance through changes in the dynamics of the drug target","volume":"117","author":"Tomlinson","year":"2020","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"10.1016\/j.actbio.2023.11.040_bib0041","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s41579-022-00682-4","article-title":"Tolerance and resistance of microbial biofilms","volume":"20","author":"Ciofu","year":"2022","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0042","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/nano11010082","article-title":"Nanotheranostics: a possible solution for drug-resistant Staphylococcus aureus and their biofilms?","volume":"11","author":"Mosselhy","year":"2021","journal-title":"Nanomaterials"},{"key":"10.1016\/j.actbio.2023.11.040_bib0043","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/phar.2806","article-title":"Current therapies and challenges for the treatment of Staphylococcus aureus biofilm-related infections","volume":"43","author":"Tran","year":"2023","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.actbio.2023.11.040_bib0044","doi-asserted-by":"crossref","first-page":"7280","DOI":"10.1128\/AAC.01118-16","article-title":"Antibiofilm activity and synergistic inhibition of Staphylococcus aureus biofilms by bactericidal protein P128 in combination with antibiotics","volume":"60","author":"Nair","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.actbio.2023.11.040_bib0045","doi-asserted-by":"crossref","first-page":"22684","DOI":"10.1021\/acsomega.0c02294","article-title":"Mechanisms and control measures of mature biofilm resistance to antimicrobial agents in the clinical context","volume":"5","author":"Li","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.actbio.2023.11.040_bib0046","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.3390\/molecules26216392","article-title":"The antibiofilm nanosystems for improved infection inhibition of microbes in skin","volume":"26","author":"Lin","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/j.actbio.2023.11.040_bib0047","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1039\/C7CS00807D","article-title":"Nanotechnology-based antimicrobials and delivery systems for biofilm-infection control","volume":"48","author":"Liu","year":"2019","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.actbio.2023.11.040_bib0048","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.jconrel.2022.06.038","article-title":"Penetration and photodynamic ablation of drug-resistant biofilm by cationic iron oxide nanoparticles","volume":"348","author":"Jin","year":"2022","journal-title":"J. Control. Release"},{"key":"10.1016\/j.actbio.2023.11.040_bib0049","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3390\/antibiotics10050581","article-title":"Targeting internalized Staphylococcus aureus using vancomycin-loaded nanoparticles to treat recurrent bloodstream infections","volume":"10","author":"Nader","year":"2021","journal-title":"Antibiotics"},{"key":"10.1016\/j.actbio.2023.11.040_bib0050","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejpb.2020.04.010","article-title":"Lipid-polymer hybrid nanoparticles carrying linezolid improve treatment of methicillin-resistant Staphylococcus aureus (MRSA) harbored inside bone cells and biofilms","volume":"151","author":"Guo","year":"2020","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.actbio.2023.11.040_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119784","article-title":"Enhanced eradication of intracellular and biofilm-residing methicillin-resistant Staphylococcus aureus (MRSA) reservoirs with hybrid nanoparticles delivering rifampicin","volume":"589","author":"Guo","year":"2020","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.actbio.2023.11.040_bib0052","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.actbio.2018.09.001","article-title":"PEGylation of model drug carriers enhances phagocytosis by primary human neutrophils","volume":"79","author":"Kelly","year":"2018","journal-title":"Acta Biomater"},{"key":"10.1016\/j.actbio.2023.11.040_bib0053","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a025437","article-title":"Fusidic acid: a bacterial elongation factor inhibitor for the oral treatment of acute and chronic Staphylococcal infections","volume":"6","author":"Fernandes","year":"2016","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.actbio.2023.11.040_bib0054","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.3390\/cancers12092437","article-title":"Lysosome as a central hub for rewiring pH homeostasis in tumors","volume":"12","author":"Chen","year":"2020","journal-title":"Cancers"},{"key":"10.1016\/j.actbio.2023.11.040_bib0055","doi-asserted-by":"crossref","first-page":"435","DOI":"10.4155\/tde-2018-0009","article-title":"Recent advances in nanomedicine for sepsis treatment","volume":"9","author":"Yuk","year":"2018","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.actbio.2023.11.040_bib0056","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.nano.2017.10.006","article-title":"Intravenous anti-MRSA phosphatiosomes mediate enhanced affinity to pulmonary surfactants for effective treatment of infectious pneumonia","volume":"14","author":"Hsu","year":"2018","journal-title":"Nanomed.-Nanotechnol. Biol. Med."},{"key":"10.1016\/j.actbio.2023.11.040_bib0057","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s11095-019-2571-1","article-title":"Pharmacokinetics, tissue distribution and excretion of Ag2S quantum dots in mice and rats: the effect of injection dosse, particle size and surface charge","volume":"36","author":"Javidi","year":"2019","journal-title":"Pharm. Res."},{"key":"10.1016\/j.actbio.2023.11.040_bib0058","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2019.01.002","article-title":"Effect of physicochemical and surface properties on in vivo fate of drug nanocarriers","volume":"143","author":"Zhao","year":"2019","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.actbio.2023.11.040_bib0059","article-title":"Biomimetic nanosponges suppress in vitro lethality induced by the whole secreted proteins of pathogenic bacteria","volume":"15","author":"Chen","year":"2019","journal-title":"Small"},{"key":"10.1016\/j.actbio.2023.11.040_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104363","article-title":"Immunopathophysiology of human sepsis","volume":"86","author":"Wiersinga","year":"2022","journal-title":"EBioMedicine"},{"key":"10.1016\/j.actbio.2023.11.040_bib0061","first-page":"263","article-title":"Bacteremia, sepsis, and infective endocarditis associated with Staphylococcus aureus","volume":"409","author":"Bergin","year":"2017","journal-title":"Curr. Top. Microbiol. Immunol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0062","doi-asserted-by":"crossref","first-page":"577","DOI":"10.3109\/00365548.2013.786836","article-title":"Short- and long-term mortality in patients with community-acquired severe sepsis and septic shock","volume":"45","author":"Storgaard","year":"2013","journal-title":"Scand. J. Infect. Dis."},{"key":"10.1016\/j.actbio.2023.11.040_bib0063","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1093\/cvr\/cvz050","article-title":"Immune cells as targets for cardioprotection: new players and novel therapeutic opportunities","volume":"115","author":"Andreadou","year":"2019","journal-title":"Cardiovasc. Res."},{"key":"10.1016\/j.actbio.2023.11.040_bib0064","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1152\/ajprenal.00477.2019","article-title":"Inhibition of PDE4\/PDE4B improves renal function and ameliorates inflammation in cisplatin-induced acute kidney injury","volume":"318","author":"Xu","year":"2020","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"10.1016\/j.actbio.2023.11.040_bib0065","doi-asserted-by":"crossref","first-page":"e1110","DOI":"10.1002\/cti2.1110","article-title":"Risk stratification biomarkers for Staphylococcus aureus bacteraemia","volume":"9","author":"Cao","year":"2020","journal-title":"Clin. Transl. Immunol"},{"key":"10.1016\/j.actbio.2023.11.040_bib0066","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/CCM.0000000000004212","article-title":"Delay in antibiotic administration is associated with mortality among septic shock patients with Staphylococcus aureus bacteremia","volume":"48","author":"Corl","year":"2020","journal-title":"Crit. Care Med."}],"container-title":["Acta Biomaterialia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706123006992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1742706123006992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T18:11:43Z","timestamp":1761675103000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1742706123006992"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1]]},"references-count":66,"alternative-id":["S1742706123006992"],"URL":"https:\/\/doi.org\/10.1016\/j.actbio.2023.11.040","relation":{},"ISSN":["1742-7061"],"issn-type":[{"value":"1742-7061","type":"print"}],"subject":[],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutrophil-targeted combinatorial nanosystems for suppressing bacteremia-associated hyperinflammation and MRSA infection to improve survival rates","name":"articletitle","label":"Article Title"},{"value":"Acta Biomaterialia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.actbio.2023.11.040","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}